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Introduction
All cells are continuously exposed to agents that damage DNA. Although much of the damage is repaired rapidly and efficiently, a significant proportion remains unrepaired during DNA replication and blocks the passage of the replication fork. In order to circumvent this damage, the cell must either employ a damage avoidance mechanism or replicate past the damaged base(s). Since the replicative polymerases are blocked by most types of damage, they have to be substituted with specialised low fidelity polymerases that are able to synthesise DNA past different lesions in a process known as translesion synthesis (TLS). The replacement of the replicative polymerase with the specialised TLS polymerase is known as a polymerase switch 1 . A central player in this polymerase switch, and indeed in almost all processes involving DNA polymerases, is the sliding clamp, PCNA. PCNA is a homotrimeric ring structure that encircles the DNA, tethers the polymerase to the DNA and thereby increases its processivity. A wealth of evidence has shown that a key step in this switching process is the mono-ubiquitination of PCNA [2] [3] [4] . In all eukaryotes studied, monoubiquitination of PCNA on lysine-164 is brought about by Rad6 and Rad18 orthologues 2, 4 . In Saccharomyces cerevisiae and Schizosaccharomyces pombe further ubiquitins are added by Ubc13-Mms2 and Rad5 (S. cerevisiae) 2 or its orthologue Rad8 (S. pombe) 5 . Poly-ubiquitination of PCNA is much harder to detect in mammalian systems, but there is increasing evidence to suggest that it does indeed occur 6, 7 . Most of the TLS polymerases belong to the Y-family and they all have ubiquitin-binding motifs in their C-terminal domains 8 , and with one exception, they also have PCNA-binding (PIP) motifs. This provides a mechanism with which they can be recruited to Ub-PCNA at stalled forks.
The trigger for PCNA ubiquitination and its biological significance
Given the central importance of PCNA ubiquitination, a crucial question to be addressed is how the ubiquitination process is regulated. RPA-coated single-stranded DNA is also known to be the trigger for activation of cell-cycle checkpoints via the ATR-ATRIP protein kinase 13 . Surprisingly however these two processes, checkpoint activation and PCNA ubiquitination, appear to be triggered independently. Evidence to support this contention has come from work with S. cerevisiae 11 , S. pombe 5 , Xenopus 14 and human cells 9 , all coming to the same conclusion.
Many processes are activated inside the cell by DNA damage. Activation does not per se mean that it is necessarily of biological importance. To examine this in the case of PCNA ubiquitination, we were able, using siRNA, to generate cell lines that expressed almost exclusively exogenous PCNA that was either wild-type, or mutated at lysine 164 such that it could not be ubiquitinated. The cell line expressing mutant PCNA was sensitive to killing by ultraviolet (UV) light and methyl methanesulfonate (MMS), which both generate replication-stalling lesions, but not to bleomycin or camptothecin, which result in double-strand breaks in cells. This proved that PCNA ubiquitination was indeed of biological importance in protecting cells against the former type of lesion.
Persistence of PCNA mono-ubiquitination after UV or HU treament
We were next interested in understanding how the cell removed ubiquitin from PCNA after the damage had gone. A clue to this had come from the discovery that the deubiquitinating enzyme USP1 was able to remove ubiquitin from Ub-PCNA, and that 6 depletion of USP1 resulted in a significant level of Ub-PCNA even in undamaged cells 15 . To examine what happened in damaged cells we employed a couple of tricks.
We used a cell line expressing two photolyases, enzymes which, when exposed to visible light, are capable of reversing the two major forms of UV damage in situ. We exposed these cells to UV, incubated them for a few hours to generate Ub-PCNA and then shone visible light on them to reverse the damage. We were surprised to find that despite removal of >90% of the damage, the PCNA remained ubiquitinated for several hours. Our next thought was that the PCNA was released from the chromatin into the nucleoplasm, where it would get diluted by the pool of unmodified PCNA.
This however turned out not to be the case. The modified PCNA remained associated with the chromatin in the triton-insoluble fraction of the cell.
In view of the unexpectedness of these findings we felt it was important to confirm them using an independent method. We therefore exposed the cells to HU for 24h to inhibit replication and generate Ub-PCNA. We then removed the HU and released the cells into cycle. A 24-hour treatment with HU resulted in the generation of a substantial amount of Ub-PCNA ( Figure 1A , lane 5), comparable to that produced after UV-irradiation ( Figure 1A , lane 1). We then removed the HU to allow cells to continue to progress through the cell cycle. The flow cytometry profile of Figure 1B shows that the cells blocked in early S by the HU treatment traversed through S phase in the first nine hours following release of the HU block and went through mitosis within 24 h. Figures 1C and D show that DNA synthesis, measured by thymidine incorporation, and cell proliferation resumed after release of the block. These data show that after release from the HU block, cells traversed through the cell cycle and retained their proliferative capacity. Nevertheless, Ub-PCNA remained at relatively 7 constant levels for at least six hours after release of the block ( Figure 1A , lanes 5-16).
As before, the Ub-PCNA remained non-extractable by triton ( Figure 1A , compare even and odd-numbered lanes). Although a small fraction, estimated at 10% of the population, appeared to remain blocked at the G1/S boundary several hours after removal of HU ( Figure 1B, 6 and 9 h time-points), this cannot account for the maintenance of PCNA ubiquitination in the whole population (Fig 1A) .
How can we reconcile the persistence of ubiquitinated PCNA with the existence of a DUB that de-ubiquitinates PCNA. A clue had already come from the D'Andrea lab, who showed that after high UV doses, USP1 disappeared from the cell 15 . They subsequently showed that USP1 normally turns over rapidly, and UV inhibits transcription of USP1 mRNA 16 . We confirmed their findings and showed that USP1 disappeared from the cell even after low UV doses, consistent with the persistence of PCNA ubiquitination after UV damage. However with other DNA damaging agents, the picture was less clear. After MMS treatment, an initial rise in PCNA ubiquitination corresponded with a drop in USP1 levels. However at later times, PCNA ubiquitination levels increased further even though USP1 levels were restored.
Furthermore following HU treatment, there was no disappearance of USP1 under any circumstances (Fig 2A) , even though PCNA ubiquitination persisted for several hours.
A comparison of the responses of USP1 to doses of UV and HU that generate similar levels of PCNA ubiquitination is shown in Figure 2B . Whereas most of the USP1 In conclusion, although our understanding of PCNA mono-ubiquitination and factors affecting its regulation has substantially increased, especially following UVirradiation, many questions remain to be answered about its role in response to other agents. 
